Found: 12
Select item for more details and to access through your institution.
Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 11, p. 1384, doi. 10.1007/s00262-006-0127-9
- By:
- Publication type:
- Article
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00297-5
- By:
- Publication type:
- Article
Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00297-5
- By:
- Publication type:
- Article
Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?
- Published in:
- Vaccines, 2018, v. 6, n. 4, p. 79, doi. 10.3390/vaccines6040079
- By:
- Publication type:
- Article
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 436, p. 1, doi. 10.1126/scitranslmed.aao5931
- By:
- Publication type:
- Article
Day-4 Myeloid Dendritic Cells Pulsed with Whole Tumor Lysate Are Highly Immunogenic and Elicit Potent Anti-Tumor Responses.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028732
- By:
- Publication type:
- Article
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-149
- By:
- Publication type:
- Article
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.
- Published in:
- 2013
- By:
- Publication type:
- clinical trial
Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4553, doi. 10.3390/cancers13184553
- By:
- Publication type:
- Article
Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02283
- By:
- Publication type:
- Article
Rate of Freeze Impacts the Survival and Immune Responses Post Cryoablation of Melanoma.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.695150
- By:
- Publication type:
- Article